2021
DOI: 10.1111/jgh.15537
|View full text |Cite
|
Sign up to set email alerts
|

We report a patient who presented intrahepatic cholangitis and cholecystitis after SARS‐CoV‐2 infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Yet, it was previously reported that anti-CRP autoantibodies have been reported in hepatitis C cases, a fact that raises further diagnostic questions for its lower levels in that condition. Acute acalculous cholecystitis case reports reveal different CRP concentrations after different various pathogenic agents (about 5 mg/L for Epstein–Barr Virus (EBV), and more than 200 mg/L in measles infection and various other intermediate values due to other viruses) [ 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 ].…”
Section: Current Evidence On C-reactive Protein and Potential Conditionsmentioning
confidence: 99%
“…Yet, it was previously reported that anti-CRP autoantibodies have been reported in hepatitis C cases, a fact that raises further diagnostic questions for its lower levels in that condition. Acute acalculous cholecystitis case reports reveal different CRP concentrations after different various pathogenic agents (about 5 mg/L for Epstein–Barr Virus (EBV), and more than 200 mg/L in measles infection and various other intermediate values due to other viruses) [ 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 ].…”
Section: Current Evidence On C-reactive Protein and Potential Conditionsmentioning
confidence: 99%